InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by GAYNOR RICHARD, Director. Insider active across 2 companies, notably Zai Lab Ltd. Aggregated, 9 filings have been published. Total volume traded: €57k. The latest transaction was disclosed on 17 March 2026 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
US$28,4651,731 shares@ US$16.44410.0012% mcap100.0% of flow
American Depositary Shares
SEC:0000905148-26-001398·
Ideal exit: 12 Dec 2026 (T+270)
€28,4651,731 shares@ €16.44410.0012% mcap50.0% of flow
American Depositary Shares
SEC:0000905148-26-001398:0·
Ideal exit: 12 Dec 2026 (T+270)
7,585 shares
Ordinary Shares
SEC:0001127602-22-017637:0·
5,578 shares
Ordinary Shares
SEC:0001127602-21-030302·
5,578 shares
Ordinary Shares
SEC:0001127602-21-030302:0·
08,912 shares0
Ordinary Shares
SEC:0000899243-21-045487·
08,912 shares0
Ordinary Shares
SEC:0000899243-21-045487:0·
06,104 shares0
Ordinary Shares
SEC:0001127602-21-017788·
06,104 shares0
Ordinary Shares
SEC:0001127602-21-017788:0·
9 of 9 declarations
About GAYNOR RICHARD
Richard Gaynor is a Director at Zai Lab Ltd and Alkermes plc. He brings valuable expertise in corporate governance and strategy. As a board member, he is involved in overseeing the operations and strategic decisions of the companies. His experience in the pharmaceutical and biopharmaceutical sectors enables him to effectively contribute to the growth and innovation of the organizations he serves.
